Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02).

Familial cancer - 1 Mar 2014

Evans D G, Thomas S, Caunt J, Roberts L, Howell A, Wilson M, Fox R, Sibbering D M, Moss S, Wallis M G, Eccles D M, Duffy S

Abstract excerpt

Although there have been encouraging recent studies showing a potential benefit from annual mammography in women aged 40-49 years of age with an elevated breast cancer risk due to family history there is little evidence of efficacy in women aged <40 years of age. A prospective study (FH02) has be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Predisposition to Disease
Share to Mammography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Risk Factors

Share to United Kingdom

Source

Identifiers

PMID: 23733252
DOI: 10.1007/s10689-013-9661-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23733252-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02).PMID 23733252Read ↗

Management of women at high risk for breast cancer: new imaging beyond mammography.Semantic proximity Read ↗

High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.Semantic proximity Read ↗

Screening for hereditary breast cancer.Semantic proximity Read ↗

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.Semantic proximity Read ↗

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.Semantic proximity Read ↗

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).Semantic proximity Read ↗

Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.Semantic proximity Read ↗

Screening of women at high risk for breast cancer.Semantic proximity Read ↗

Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.Semantic proximity Read ↗

[New information on high risk breast screening].Semantic proximity Read ↗

The UK breast screening program - what you need to know.Semantic proximity Read ↗

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.